Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Kub5-Hera RPRD1B Deficiency Promotes "BRCAness" and Vulnerability to PARP Inhibition in BRCA-proficient Breast Cancers.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Kub5-Hera RPRD1B Deficiency Promotes "BRCAness" and Vulnerability to PARP Inhibition in BRCA-proficient Breast Cancers.
Kub5-Hera RPRD1B Deficiency Promotes "BRCAness" and Vulnerability to PARP Inhibition in BRCA-proficient Breast Cancers. Clin Cancer Res. 2018 12 15; 24(24):6459-6470.
View in:
PubMed
subject areas
Animals
Animals
Breast Neoplasms
Breast Neoplasms
CDC2 Protein Kinase
CDC2 Protein Kinase
Cell Cycle Proteins
Cell Cycle Proteins
Cell Line, Tumor
Cell Line, Tumor
Disease Models, Animal
Disease Models, Animal
DNA Damage
DNA Damage
Female
Female
Gene Expression Regulation, Neoplastic
Gene Expression Regulation, Neoplastic
Genes, BRCA1
Genes, BRCA1
Genes, BRCA2
Genes, BRCA2
Genes, Reporter
Genes, Reporter
Humans
Humans
Mice
Mice
Mutation
Mutation
Neoplasm Proteins
Neoplasm Proteins
Poly(ADP-ribose) Polymerase Inhibitors
Poly(ADP-ribose) Polymerase Inhibitors
Poly(ADP-ribose) Polymerases
Poly(ADP-ribose) Polymerases
Promoter Regions, Genetic
Promoter Regions, Genetic
Synthetic Lethal Mutations
Synthetic Lethal Mutations
Xenograft Model Antitumor Assays
Xenograft Model Antitumor Assays
authors with profiles
Julio C. Morales